Literature DB >> 1730681

Structure of the L2 lipopolysaccharide core oligosaccharides of Neisseria meningitidis.

A Gamian1, M Beurret, F Michon, J R Brisson, H J Jennings.   

Abstract

Three different oligosaccharides were identified following mild acid hydrolysis of the lipopolysaccharide obtained from Neisseria meningitidis serotype 2 and their structures elucidated by combined chemical and physical techniques. The use of 500 MHz 1H nmr in both one- and two-dimensional modes as well as nuclear Overhauser effect experiments were employed. To assist in the structural assignments the oligosaccharides were also degraded by chemical and enzymatic procedures to smaller fragments. The oligosaccharides were all triantennary nonasaccharides in which the longest antenna terminates in lacto-N-neotetraose. Two of the nonasaccharides (major components), not separable by column chromatography, were distinguishable only by their different patterns of phosphorylethanolamine substitution and the third minor component by the absence of this substituent.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730681

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Structural and immunochemical characterization of the lipooligosaccharides expressed by Neisseria subflava 44.

Authors:  Y Tong; V Reinhold; B Reinhold; B Brandt; D C Stein
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

2.  Phosphorylation of the lipid A region of meningococcal lipopolysaccharide: identification of a family of transferases that add phosphoethanolamine to lipopolysaccharide.

Authors:  Andrew D Cox; J Claire Wright; Jianjun Li; Derek W Hood; E Richard Moxon; James C Richards
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

3.  Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis.

Authors:  Margaret Anne J Gidney; Joyce S Plested; Suzanne Lacelle; Philip A Coull; J Claire Wright; Katherine Makepeace; Jean-Robert Brisson; Andrew D Cox; E Richard Moxon; James C Richards
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

4.  The oligosaccharide of gonococcal lipooligosaccharide contains several epitopes that are recognized by human antibodies.

Authors:  Ryohei Yamasaki; Uichirou Yabe; Chikako Kataoka; Ushio Takeda; Shunpei Asuka
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

5.  Analysis of lipooligosaccharide biosynthesis in the Neisseriaceae.

Authors:  D Arking; Y Tong; D C Stein
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

6.  Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B.

Authors:  Deborah H Schmiel; Elizabeth E Moran; Paul B Keiser; Brenda L Brandt; Wendell D Zollinger
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

7.  Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity.

Authors:  E E Moran; B L Brandt; W D Zollinger
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Genetic and structural characterization of L11 lipooligosaccharide from Neisseria meningitidis serogroup A strains.

Authors:  Noëlle Mistretta; Delphine Seguin; Jerôme Thiébaud; Sandrine Vialle; Frédéric Blanc; Marina Brossaud; Philippe Talaga; Gunnstein Norheim; Monique Moreau; Bachra Rokbi
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

9.  Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response.

Authors:  V Weynants; P Denoël; N Devos; D Janssens; C Feron; K Goraj; P Momin; D Monnom; C Tans; A Vandercammen; F Wauters; Jan T Poolman
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

Review 10.  Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.

Authors:  A F Verheul; H Snippe; J T Poolman
Journal:  Microbiol Rev       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.